Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Hepatitis C treatment
10 patients safely receive hepatitis C-infected lungs in new clinical trial

Researchers behind a bold experiment to use hepatitis C-infected lungs for transplant say such organs could help address a critical shortage of donors and make “some good come out” of the increasing number of opioid-related deaths.

Published
14 June 2018
From
CTV
Hepatitis C treatment
EATG launches a report on access to HCV-related services in the penitentiary system in Europe

Drawing on research on the state of access to services related to Hepatitis C in prison settings in Europe and Central Asia, which has highlighted major shortcomings across the countries as well as some promising practices in few countries, the European AIDS Treatment Group calls on national and prison authorities to scale up access to voluntary and confidential testing and counselling for people in detention.

Published
23 May 2018
From
EATG
Hepatitis C treatment
Do direct acting antivirals cure chronic hepatitis C?

We were dismayed that the Editors of the BMJ presented the widely discredited Cochrane review of Hepatitis C virus therapy as mainstream opinion. It is not... There is no credible explanation for the fall in hepatitis C liver disease morbidity and mortality associated with the introduction of effective anti-virals other than the use of these drugs.

Published
18 May 2018
From
BMJ
Hepatitis C treatment
How states could be saving more hepatitis C patients

USC’s Neeraj Sood and colleagues propose an approach that leverages competition among drug manufacturers, saving states money and ensuring that more people get treatment

Published
15 May 2018
From
USC News
Access to medicines and treatment
Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position toward the high prices of medicines, as high-income countries were also faced with an untenable burden to their health systems. In a number of lower and middle-income countries civil society organised itself to increase access to sofosbuvir for millions in need.

Published
14 May 2018
From
Intellectual Property Watch
Pharmaceutical industry
Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble

Sales of hepatitis C drugs Harvoni, Sovaldi and Epclusa raked in $1.05 billion, declining 59%. That was the single biggest year-over-year decline in the eight quarters since Gilead started reporting sales of hepatitis C drugs separately from its other antiviral products.

Published
02 May 2018
From
Investor's Business Daily
Hepatitis C treatment
Many European countries are not ready to stop viral hepatitis

Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries. The Hep-CORE study was coordinated by ISGlobal - an institution supported by the "la Caixa" Foundation - and led by the European Liver Patient's Association.

Published
19 April 2018
From
Eurekalert Medicine & Health
Hepatitis C treatment
Linkage to care specialist facilitates access to hepatitis C treatment for people who inject drugs

A longitudinal study involving more than 1,000 individuals reports promising role for linkage to care specialists in expanding access to hepatitis C treatment for people who inject drugs. Almost 50% of patients referred to a medical practitioner made it to their first appointment and that 60% of those seen were initiated on treatment.

Published
13 April 2018
From
Eurekalert Inf Dis
Hepatitis C treatment
How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds?

A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Published
10 April 2018
From
Poz
Hepatitis C treatment
Newly Discovered HCV Subtype is Resistant to Antiviral Treatment

A newly discovered hepatitis C virus (HCV) genotype 1 subtype harbors multiple resistance-associated mutations that combine to block therapeutic effect of NS5A inhibitor direct-acting antivirals (DAAs).

Published
21 March 2018
From
MD Magazine
← Prev1...34567...75Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.